Key result
Whole exome sequencing identifies ANO5-related distal myopathy in a patient with HCM and post-COVID myopericarditis.
Why the study?
Hypertrophic cardiomyopathy complicated by post-COVID-19 myopericarditis in a patient with ANO5-related distal myopathy presents a complex clinical scenario requiring detailed characterization.
Case Report (n=1)
This case highlights the potential for genetically modified myocardium in ANO5-related distal myopathy to serve as a susceptible background for post-COVID-19 myopericarditis and heart failure decompensation.
Answers are grounded in this paper and cite their sources.
May suggest ANO5 variants increase susceptibility to post-COVID myopericarditis in HCM; hypothesis-generating and requires validation before clinical implications.
A 60-year-old male with hypertrophic cardiomyopathy, conduction disorders, post-COVID-19 myopericarditis and heart failure was admitted to the hospital’s cardiology department. Blood tests revealed an increase in CPK activity, troponin T elevation and high titers of anticardiac antibodies. Whole exome sequencing showed the presence of the pathogenic variant NM_213599:c.2272C>T of the ANO5 gene. Results of the skeletal muscle biopsy excluded the diagnosis of systemic amyloidosis. Microscopy of the muscle fragment demonstrated sclerosis of the perimysium, moderate lymphoid infiltration, sclerosis of the microvessels, dystrophic changes and a lack of cross striations in the muscle fibers. Hypertrophy of the LV with a low contractile ability, atrial fibrillation, weakness of the distal skeletal muscles and increased plasma CPK activity and the results of the skeletal muscle biopsy suggested a diagnosis of a late form of distal myopathy (Miyoshi-like distal myopathy, MMD3). Post-COVID-19 myopericarditis, for which genetically modified myocardium could serve as a favorable background, caused heart failure decompensation.
No takes yet. Share an insight, caveat, or question.
Благова et al. (2023) conducted a case report in Hypertrophic cardiomyopathy, post-COVID-19 myopericarditis, ANO5-related distal myopathy (n=1). Whole exome sequencing and skeletal muscle biopsy was evaluated. A 60-year-old male with hypertrophic cardiomyopathy and post-COVID-19 myopericarditis was diagnosed with ANO5-related distal myopathy following whole exome sequencing and muscle biopsy.
Synapse has enriched 10 related papers. Consider them for comparative context: